Question 1

Does Farallon Capital Management own BEAM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Farallon Capital Management holds 10,236,396 shares of BEAM (Beam Therapeutics), worth $351.3M.

Question 2

How many shares of BEAM does Farallon Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Farallon Capital Management holds 10,236,396 shares of BEAM (Beam Therapeutics).

Question 3

What is Farallon Capital Management's BEAM position worth?

Accepted Answer

As of its Q2 2026 13F, Farallon Capital Management's BEAM position is worth $351.3M.

Question 4

Is Farallon Capital Management buying or selling BEAM?

Accepted Answer

In Q2 2026, Farallon Capital Management increased its BEAM position by 101,700 shares (+1.0%).

Question 5

When did Farallon Capital Management first buy BEAM?

Accepted Answer

Farallon Capital Management already held BEAM in its Q1 2020 13F, the earliest on record, and has listed it in 23 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	10.2M	+1.0%	$351.3M	1.6%	$34.32	49
2026-Q1	Increased	10.1M	+0.7%	$241.5M	1.3%	$27.22	49
2025-Q4	Unchanged	10.1M	0.0%	$278.9M	1.2%	$27.82	0
2025-Q3	Increased	10.1M	+0.5%	$244.2M	1.0%	$23.91	43
2025-Q2	Increased	10M	+0.9%	$170.3M	0.7%	$16.80	43
2025-Q1	Increased	9.9M	+20.5%	$193.9M	0.9%	$22.21	51
2024-Q4	Increased	8.2M	+0.4%	$204.3M	0.9%	$25.27	43
2024-Q3	Increased	8.2M	+3.7%	$201.1M	0.9%	$25.05	45

BEAMShowing 8 of 24 quarters

BEAM
Showing 8 of 24 quarters